SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 206.84+2.8%Nov 18 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (17579)3/18/1998 9:28:00 AM
From: Sleepman  Read Replies (4) of 32384
 
Henry,
The news is now out about the leptin deal.
My humble analysis does not think it is all that great, but I am interested in others opinions. SmithKlein gets the compound for relatively little stock and royalties that were not outlined in the press release. LGND gets more dilution of shares and unclear milestone payments and royalties. Do you really think that this is a good deal? Dan
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext